Literature DB >> 18528677

Metformin and the intestine.

C J Bailey, C Wilcock, J H B Scarpello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18528677     DOI： 10.1007/s00125-008-1053-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  9 in total

1.  Sites of metformin-stimulated glucose metabolism.

Authors:  C Wilcock; C J Bailey
Journal:  Biochem Pharmacol       Date:  1990-06-01       Impact factor: 5.858

2.  Reconsideration of inhibitory effect of metformin on intestinal glucose absorption.

Authors:  C Wilcock; C J Bailey
Journal:  J Pharm Pharmacol       Date:  1991-02       Impact factor: 3.765

Review 3.  Metformin.

Authors:  C J Bailey; R C Turner
Journal:  N Engl J Med       Date:  1996-02-29       Impact factor: 91.245

4.  Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

Authors:  G T Tucker; C Casey; P J Phillips; H Connor; J D Ward; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

5.  Accumulation of metformin by tissues of the normal and diabetic mouse.

Authors:  C Wilcock; C J Bailey
Journal:  Xenobiotica       Date:  1994-01       Impact factor: 1.908

Review 6.  Metformin and its liver targets in the treatment of type 2 diabetes.

Authors:  Jerry Radziuk; Clifford J Bailey; Nicolas F Wiernsperger; John S Yudkin
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-06

7.  Effect of metformin on glucose metabolism in the splanchnic bed.

Authors:  C J Bailey; C Wilcock; C Day
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

8.  Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine.

Authors:  L Pénicaud; Y Hitier; P Ferré; J Girard
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

9.  Importance of the intestine as a site of metformin-stimulated glucose utilization.

Authors:  C J Bailey; K J Mynett; T Page
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739
  9 in total
  81 in total

1.  Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.

Authors:  Lulu Sun; Cen Xie; Guang Wang; Yue Wu; Qing Wu; Xuemei Wang; Jia Liu; Yangyang Deng; Jialin Xia; Bo Chen; Songyang Zhang; Chuyu Yun; Guan Lian; Xiujuan Zhang; Heng Zhang; William H Bisson; Jingmin Shi; Xiaoxia Gao; Pupu Ge; Cuihua Liu; Kristopher W Krausz; Robert G Nichols; Jingwei Cai; Bipin Rimal; Andrew D Patterson; Xian Wang; Frank J Gonzalez; Changtao Jiang
Journal:  Nat Med       Date:  2018-11-05       Impact factor: 53.440

2.  Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial.

Authors:  Mette Marie H Christensen; Kurt Højlund; Ole Hother-Nielsen; Tore B Stage; Per Damkier; Henning Beck-Nielsen; Kim Brøsen
Journal:  Diabetologia       Date:  2015-08-14       Impact factor: 10.122

3.  Therapy: Metformin takes a new route to clinical efficacy.

Authors:  Marc Foretz; Benoit Viollet
Journal:  Nat Rev Endocrinol       Date:  2015-06-02       Impact factor: 43.330

4.  Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers.

Authors:  Tianxiang Kevin Han; William R Proctor; Chester L Costales; Hao Cai; Ruth S Everett; Dhiren R Thakker
Journal:  J Pharmacol Exp Ther       Date:  2015-01-06       Impact factor: 4.030

5.  Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes.

Authors:  Lars C Gormsen; Esben Søndergaard; Nana L Christensen; Kim Brøsen; Niels Jessen; Søren Nielsen
Journal:  Diabetologia       Date:  2019-04-11       Impact factor: 10.122

6.  A Western diet-induced mouse model reveals a possible mechanism by which metformin decreases obesity.

Authors:  Frank J Gonzalez; Changtao Jiang
Journal:  Eur J Clin Pharmacol       Date:  2017-08-22       Impact factor: 2.953

Review 7.  Cultivation of the Next-Generation Probiotic Akkermansia muciniphila, Methods of Its Safe Delivery to the Intestine, and Factors Contributing to Its Growth In Vivo.

Authors:  Anastasiia V Ropot; Andrei M Karamzin; Oleg V Sergeyev
Journal:  Curr Microbiol       Date:  2020-04-21       Impact factor: 2.188

Review 8.  Metformin: New Preparations and Nonglycemic Benefits.

Authors:  Yoshihito Fujita; Nobuya Inagaki
Journal:  Curr Diab Rep       Date:  2017-01       Impact factor: 4.810

9.  Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication.

Authors:  Alessandro Protti; Riccarda Russo; Paola Tagliabue; Sarah Vecchio; Mervyn Singer; Alain Rudiger; Giuseppe Foti; Anna Rossi; Giovanni Mistraletti; Luciano Gattinoni
Journal:  Crit Care       Date:  2010-02-19       Impact factor: 9.097

Review 10.  Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.

Authors:  Abd A Tahrani; Anthony H Barnett; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2016-06-24       Impact factor: 43.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.